Tidepool

We did it!!! Groundbreaking news: Tidepool Loop receives FDA Clearance! This is the first ever fully interoperable automated insulin dosing app, cleared by the FDA that began as a patient-led initiative. Find the inside scoop on all things Tidepool Loop and what this means on our website: https://lnkd.in/gKUD7_cq

📚 The next case study in our regulatory case study series highlights Tidepool Tidepool. This nonprofit transformed a patient-driven automated insulin dosing app into the first FDA-cleared, fully interoperable solution! 🔧 Many patients with insulin-dependent diabetes have resorted to creating DIY solutions out of frustration with existing diabetes tech limitations. Without regulated guidance, these solutions raise safety concerns. Tidepool led the charge to develop a regulated alternative focused on interoperability and patient choice. 🚀 Through early engagement, Tidepool embarked on an expedited pathway with the FDA, allowing an independent review of interoperable components. This early engagement streamlined Tidepool’s pathway to 510(k) regulatory clearance, providing more choices for the diabetes community. 🌟 Learn more about Tidepool’s innovative journey and regulatory strategy: Full Case Study 📖 View all 10 case studies to learn more about navigating the regulatory environment to bring DHTs to market: https://bit.ly/3WWdf90

Empathy-driven innovation - balancing the need to be more efficient and accessible, while remaining deeply attuned to the needs of those you serve. But how do you find time to focus on patient experience, when the world seems to change every day? This past week, we had the absolute honor to host an enlightening Digital Health Summit at MATTER HQ in Chicago, bringing together industry leaders from Advocate Health, Froedtert Health, Tidepool and Pixel Health. The focus? Merging excellent care delivery with exceptional service. The consensus was clear: healthcare must pivot from merely providing care to delivering outstanding service experiences, emphasizing patient-centered design and what to do in the wake of recent retail health events. Ensuring every patient interaction is not just functional but truly remarkable. Thank you to Jamey Shiels, Erin DeJarlais, PT, MBA, DPT, Edward Mitchell, MBA, Christian Lagier, Izzy Goodwin, MBA, Jennifer Moore and Tom S. Lee and our own Laurance Stuntz and Aaron Sheedy for the great conversation! Join us as we continue to transform healthcare through innovation and empathy. #DigitalHealth #PatientExperience #HealthcareInnovation #XealthSummit https://lnkd.in/gx97brjR

The Digital Medicine Society (DiMe) has built out a set of new industry case studies illustrating how organizations have engaged with the FDA to successfully navigate the regulatory landscape and gain the appropriate authorization to bring their products to market - including a great narrative on how Tidepool successfully championed Tidepool Loop!

Very happy to see a topic close to my heart getting more attention! The impact of the menstrual cycle on insulin sensitivity in women with Type 1 diabetes is scientifically neglected and often overlooked. Excited about our collaboration with Tidepool to shed more light on this important issue! #Type1Diabetes #Tidepool

Do you know a #Type1Diabetes Family of Color or #T1D Young Adult (ages 12-21)? Please share this research opportunity Stanford University's Addala Lab! Open nationally (USA) to anyone utilizing public insurance; all visits will be virtual & compensated🧑💻👩💻 🌀 The goal of the study is to collect real life experiences from T1Ds of Color in order to ✨build the evidence to address disparities in T1D✨ (BEAD-T1D). ✍️ Submit interest here: redcap.link/BEADT1D Type 1 Diabetes is a relentless, complex, and individualized chronic condition at the base level. I've long been aware of the vast health inequities Black people & People of Color face in the medical system, but reading "Diabetes: A History of Race and Disease"* opened my eyes to layers of the onion I've been fortunate enough to not experience first hand. I can't recommend this book enough, and hope that some day it is required reading for medical practitioners, especially those in #endocrinology, ER docs+nurses (where T1Ds encounter the most stigma/bias and therefore poor care). Researchers/doctors like Dr. Addala (and some tagged below) give me hope for a better tomorrow for *ALL* T1Ds, not just those who have generational wealth or jobs with good insurance. cc for visibility & reach - recruiting for this began yesterday and I'd love to help Dr. Addala's team get the study going (I'm doing this simply because I care about finding solutions for these problems & LinkedIn is a place to gain untapped traction) - please share to anyone in the T1D community who could possibly be interested in this study or would know someone in their network. Jenna Beart Bollyky Craig Stubing James Elliott Krystal Kobasic Korey Hood Gloria Cheng Lorraine Hoover Beta Cell Foundation Jordan Fogle, MM Paula Clinton (Mason) RD, CDCES Patrick Haggerty Matt Mahowald Christopher Snider Annie Shultz Elijah Moore Rezaul Hoque (in case you met anyone in US who could be a fit) Kelsey Duman, MNLM Tidepool Manuel Hernández Benaroya Research Institute Diabetes Research Connection The Diabetes Link Livongo Bigfoot Biomedical Tandem Diabetes Care Dexcom Medtronic Insulet Corporation Abbott Thrivable Children With Diabetes Association of Diabetes Care & Education Specialists Diabetes Hands Foundation Diabetes Foundation JDRF International The diaTribe Foundation Laura WhittonClose Beyond Type 1 (please stop taking insulin manufacturer $, or start fighting like hell for regulation of the price of insulin (patient assistance programs are NOT enough!)) #T1DResearch #T1DLooksLikeMe #DiabeticsDoingThings #DiagnosedNotDefeated #DiaBadAss #DiversityInDiabetes #SmallStepsBigChanges #NavidatingDiabetes #HealthEquity #DiabetesAwareness #DiversityInHealth #SocialDeterminants #RacialEquity #HealthcareDisparities #AdvocacyInAction #SustainableHealthcare #DiabetesCare #UnderservedCommunities #PublicHealth #InclusiveHealthcare #DiabetesAdvocacy #HealthJustice #MinorityHealth

We are thrilled to announce that Tidepool has achieved SOC 2 Type II compliance! 🏅 This is a testament to the robust capabilities of the Tidepool Data Platform, our development practices, and security compliance mechanisms. Read the full press release here: https://bwnews.pr/4cF00PD #DataSecurity #SOC2TypeII #DiabetesData

We are excited to announce a new collaboration with Sequel Med Tech, LLC! Sequel’s new twiist™ Automated Insulin Delivery (AID) system powered by Tidepool, just received FDA 510(k) clearance. 🎉 Check out our announcement blog post to learn more: https://bit.ly/4ao7ch7

To learn more and participate in this study: https://lnkd.in/g_QyPtuH

It is so wonderful to be a part of a collection of researchers and industry working towards solutions that help reduce the burden of exercising while living with diabetes. Thank you, The Helmsley Charitable Trust, for your support! https://lnkd.in/gNY_Cgbe